$0.01 EPS Expected for Materialise NV (MTLS); 6 Analysts Bullish Tandem Diabetes Care, Inc. (TNDM)

April 25, 2018 - By Marguerite Chambers

Materialise NV (NASDAQ:MTLS) Logo

Among 11 analysts covering Tandem Diabetes Care (NASDAQ:TNDM), 6 have Buy rating, 1 Sell and 4 Hold. Therefore 55% are positive. Tandem Diabetes Care had 25 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was upgraded by Cowen & Co on Wednesday, March 28 to “Buy”. As per Monday, August 10, the company rating was maintained by Deutsche Bank. Bank of America downgraded the stock to “Underperform” rating in Thursday, March 24 report. The firm has “Hold” rating given on Thursday, October 5 by Piper Jaffray. PiperJaffray downgraded the stock to “Neutral” rating in Thursday, November 3 report. The rating was downgraded by Stifel Nicolaus to “Hold” on Wednesday, November 2. The firm earned “Underperform” rating on Monday, November 20 by Bank of America. Piper Jaffray downgraded the stock to “Neutral” rating in Thursday, November 3 report. On Wednesday, November 2 the stock rating was maintained by Deutsche Bank with “Buy”. The rating was downgraded by Bank of America to “Neutral” on Thursday, January 14. See Tandem Diabetes Care, Inc. (NASDAQ:TNDM) latest ratings:

28/03/2018 Broker: Cowen & Co Rating: Buy New Target: $7.0000 Upgrade
23/03/2018 Broker: Robert W. Baird Old Rating: Neutral New Rating: Outperform Upgrade
02/03/2018 Broker: Stifel Nicolaus Rating: Hold New Target: $4.0 Maintain
27/02/2018 Broker: Cowen & Co Rating: Hold New Target: $5.0 Maintain
27/02/2018 Broker: Oppenheimer Rating: Outperform New Target: $5.5 Initiates Coverage On
20/11/2017 Broker: Bank of America Rating: Underperform Old Target: $20 New Target: $2 Maintain
17/11/2017 Broker: Robert W. Baird Rating: Hold New Target: $3.0 Maintain

Analysts expect Materialise NV (NASDAQ:MTLS) to report $0.01 EPS on May, 8.They anticipate $0.03 EPS change or 150.00% from last quarter’s $-0.02 EPS. MTLS’s profit would be $473,254 giving it 293.75 P/E if the $0.01 EPS is correct. After having $0.04 EPS previously, Materialise NV’s analysts see -75.00% EPS growth. The stock increased 0.69% or $0.08 during the last trading session, reaching $11.75. About 20,308 shares traded. Materialise NV (NASDAQ:MTLS) has risen 41.18% since April 25, 2017 and is uptrending. It has outperformed by 29.63% the S&P500.

The stock increased 1.83% or $0.13 during the last trading session, reaching $7.22. About 639,176 shares traded. Tandem Diabetes Care, Inc. (NASDAQ:TNDM) has declined 63.92% since April 25, 2017 and is downtrending. It has underperformed by 75.47% the S&P500.

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company has market cap of $322.73 million. The companyÂ’s flagship product is the t:slim X2 insulin delivery system that comprises t:slim X2 pump, its disposable insulin cartridge, and an infusion set. It currently has negative earnings. It also provides t:flex insulin delivery system that includes t:flex pump, its 480-unit disposable insulin cartridge, and an infusion set; and t:slim G4 insulin delivery system, a touch-screen pump with an integrated CGM system.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marguerite Chambers

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: